Age-sex, ethnic and genetic peculiarities of high normal arterial blood pressure in residents of Mountain Shoria

Aim. To study the prevalence of a high normal arterial blood pressure (HNABP) depending on the age-sex and ethnic characteristics of the population of Mountain Shoria and its association with the cardiovascular risk factors and genetic markers. Materials and methods. We performed a cross-sectional study of the compactly settled population in the isolated areas of Mountain Shoria (Orton and Ust-Kabyrza villages) and in urban-type settlement Sheregesh. The sample of the Shor population was 901 subjects (284 men and 617 women). As the comparison group, we examined 508 non-indigenous (newly arrived) subjects (153 men and 355 women) in the indicated villages. All the respondents underwent a general clinical laboratory and instrumental examination. Polymorphisms of genes ACE (I/D, rs 4340), АGT (c.803T>C, rs699), AGTR1 (А1166С, rs5186), ADRB1 (с.145A>G, Ser49Gly, rs1801252), ADRA2B (I/D, rs 28365031), MTHFR (c.677С>Т, Ala222Val, rs1801133) and NOS3 (VNTR, 4b/4a) were tested using polymerase chain reaction. Results. The factors associated with HNABP are analyzed in the present research. In the group of the Shors the following conditions were associated with this pathology: obesity (OR 2.03), its abdominal type (OR 1.98), genotype I/D of АСЕ gene (OR 1.80) and genotype А/С of AGTR1 gene (OR 2.03); in the non-indigenous ethnic group - obesity (OR 2.39), abdominal obesity (OR 3.17) and genotype D/D of АСЕ gene (OR 3.43). In the Shor patients with HNABP the prevalence of left ventricular myocardial hypertrophy (28.1%) and albuminuria (17.3%) appeared to be higher as compared to the non-indigenous subjects - 17.2%, (р=0.047) and 5.1% (р=0.049), respectively. Conclusion. The present study demonstrated a high prevalence of HNABP in the population of Mountain Shoria depending on ethnicity. Therefore, such patients require monitoring for an early detection of the increased blood pressure, control of risk factors, preventive examinations and dispensary observation.

high normal arterial blood pressure, cardiovascular risk factors, ethnicity

1. Rivera-Mancía S, Colín-Ramírez E, Cartas-Rosado R et al. Indicators of accumulated fat are stronger associated with prehypertension compared with indicators of circulating fat: A cross-sectional study. Medicine (Baltimore). 2018; 97 (34): 11869. DOI: 10.1097/MD.0000000000011869

2. Чевплянская О.Н., Дударев М.В. Распространенность факторов риска и ранние признаки поражения сердца у лиц молодого возраста с высоким нормальным артериальным давлением. Практ. медицина. 2015; 5 (90): 133-7. @@Chevplyanskaya O.N., Dudarev M.V. Rasprostranennost' faktorov riska i rannie priznaki porazheniia serdtsa u lits molodogo vozrasta s vysokim normal'nym arterial'nym davleniem. Prakt. meditsina. 2015; 5 (90): 133-7 (in Russian).]

3. Ефремова Ю.Е., Ощепкова Е.В., Жернакова Ю.В. и др. Факторы риска сердечно-сосудистых заболеваний у лиц с высоким нормальным артериальным давлением в Российской Федерации (по данным эпидемиологического исследования ЭССЕ-РФ). Системные гипертензии. 2017; 14 (1): 6-11. @@Efremova Yu.E., Oshchepkova E.V., Zhernakova Yu.V. et al. Cardiovascular risk factors in people with high normal blood pressure in Russian population (based on data obtained in ESSE-RF epidemiological study). Systemic Hypertension. 2017; 14 (1): 6-11 (in Russian).]

4. Бойцов С.А. Реалии и перспективы дистанционного мониторинга артериального давления у больных артериальной гипертензией. Терапевтический архив. 2018; 90 (1): 4-8. @@Boytsov S.A. Realii i perspektivy distantsionnogo monitoringa arterial'nogo davleniia u bol'nykh arterial'noi gipertenziei. Therapeutic Archive. 2018; 90 (1): 4-8. DOI: 10.17116/terarkh20189014-8 (in Russian).]

5. Чазова И.Е., Ощепкова Е.В. Результаты реализации программы по борьбе с артериальной гипертонией в России в 2002-2012 гг. Терапевтический архив. 2013; 85 (1): 4-9. @@Chazova I.E., Oshchepkova E.V. Rezul'taty realizatsii programmy po bor'be s arterial'noi gipertoniei v Rossii v 2002-2012 gg. Therapeutic Archive. 2013; 85 (1): 4-9. (in Russian).]

6. Materson B.J, Garcia-Estrada M, Degraff S.B, Preston R.A. Prehypertension is real and can be associated with target organ damage. J Am Soc Hypertens 2017; 11 (11): 704-8. DOI: 10.1016/j.jash.2017.09.005

7. Liu B, Chen Z, Dong X, Qin G. Association of prehypertension and hyperhomocysteinemia with subclinical atherosclerosis in asymptomatic Chinese: a cross-sectional study. BMJ Open 2018; 8 (3): e019829. DOI: 10.1136/bmjopen-2017-019829

8. Шаханова А.Т., Аукенов Н.Е., Нуртазина А.У. Полиморфизмы генов при артериальной гипертензии: ренин-ангиотензин-альдостероновая система. Обзор литературы. Наука и здравоохранение. 2018; 1: 116-30. @@Shakhanova A.T., Aukenov N.E., Nurtazina A.U. Polimorfizmy genov pri arterial'noi gipertenzii: renin-angiotenzin-al'dosteronovaia sistema. Obzor literatury. Nauka i zdravookhranenie. 2018; 1: 116-30 (in Russian).]

9. Мулерова Т.А. Клинические и генетические факторы, определяющие поражения органов-мишеней у пациентов с артериальной гипертензией среди населения Горной Шории. Системные гипертензии. 2017; 14 (3): 42-50. @@[Mulerova T.A. Clinical and genetic factors determining target lesions of patients with arterial hypertension among Mountain Shoria population. Systemic Hypertension. 2017; 14 (3): 42-50 (in Russian).]

10. Erem C, Hacihasanoglu A, Kocak M et al. Prevalence of prehypertension and hypertension and associated risk factors among Turkish adults: Trabzon Hypertension Study. J Public Health (Oxf). 2009; 31 (1): 47-58. DOI: 10.1093/pubmed/fdn078

11. Grotto I, Grossman E, Huerta M, Sharabi Y. Prevalence of prehypertension and associated cardiovascular risk profiles among young Israeli adults. Hypertension 2006; 48: 254-9. DOI: 10.1161/01.HYP.0000227507.69230.fc

12. Chen C, Yuan Z. Prevalence and risk factors for prehypertension and hypertension among adults in Central China from 2000-2011. Clin Exp Hypertens 2018; 7: 1-10. DOI: 10.1080/10641963.2018.1431252

13. Bhimma R, Naicker E, Gounden V et al. Prevalence of Primary Hypertension and Risk Factors in Grade XII Learners in KwaZulu-Natal, South Africa. Int J Hypertens 2018; 2018: 3848591. DOI: 10.1155/2018/3848591.

14. Simons A, Moreland C.J, Kushalnagar P. Prevalence of self-reported hypertension in deaf adults who use American sign language. Am J Hypertens 2018. DOI: 10.1093/ajh/hpy111

15. Синицкий М.Ю., Понасенко А.В., Груздева О.В. Генетический профиль и секретом адипоцитов висцеральной и подкожной жировой ткани у пациентов с сердечно-сосудистыми заболеваниями. Комплексные проблемы сердечно-сосудистых заболеваний. 2017; 3: 155-65. DOI: 10.17802/2306-1278-2017-6-3-155-165 @@Sinitskii M.Iu., Ponasenko A.V., Gruzdeva O.V. Geneticheskii profil' i sekretom adipotsitov vistseral'noi i podkozhnoi zhirovoi tkani u patsientov s serdechno-sosudistymi zabolevaniiami. Kompleksnye problemy serdechno-sosudistykh zabolevanii. 2017; 3: 155-65. DOI:10.17802/2306-1278-2017-6-3-155-165 (in Russian).]

16. Kannel W.B. Risk stratification in hypertension: new insights from the Framingham Study. Am J Hypertens 2000; 13 (1): 3-10.

17. Hu L, Huang X, You C et al. Prevalence and risk factors of prehypertension and hypertension in Southern China. PLoS One 2017; 12 (1): e0170238. DOI: 10.1371/journal.pone.0170238

18. Tabrizi J.S, Sadeghi-Bazargani H, Farahbakhsh M et al. Prevalence and associated factors of prehypertension and hypertension in Iranian population: The Lifestyle Promotion Project (LPP). PLoS One 2016; 11 (10): e0165264. DOI: 10.1371/journal.pone.0165264

19. Ononamadu C.J, Ezekwesili C.N, Onyeukwu O.F et al. Comparative analysis of anthropometric indices of obesity as correlates and potential predictors of risk for hypertension and prehypertension in a population in Nigeria. Cardiovasc J Afr 2017; 28 (2): 92-9. DOI: 10.5830/CVJA-2016-061

20. Liu B, Dong X, Xiao Y et al. Variability of metabolic risk factors associated with prehypertension in males and females: a cross-sectional study in China. Arch Med Sci 2018; 14 (4): 766-72. DOI: 10.5114/aoms.2018.76066

21. Khosravi A, Emamian M.H, Hashemi H, Fotouhi A. Pre-hypertension and the risk of diabetes mellitus incidence using a marginal structural model in an Iranian prospective cohort study. Epidemiol Health 2018; 40 (0): e2018026-0. DOI: 10.4178/epih.e2018026

22. Ehret G.B. Genome-wide association studies: Contribution of genomics to understanding blood pressure and essential hypertension. Curr Hypertens Rep 2010; 12 (1): 17-25. DOI: 10.1007/s11906-009-0086-6

23. Singh M, Singh A.K, Pandey P et al. Molecular genetics of essential hypertension. Clin Exp Hypertens 2016; 38 (3): 268-77. DOI: 10.3109/10641963.2015.1116543

24. Al-Saikhan F.I, Abd-Elaziz M.A, Ashour R.H. Association between risk of type 2 diabetes mellitus and angiotensin-converting enzyme insertion/deletion gene polymorphisms in a Saudi Arabian population. Biomed Rep 2017; 7 (1): 56-60. DOI: 10.3892/br.2017.920

25. Tchelougou D, Kologo J.K., Karou S.D et al. Renin-angiotensin system genes polymorphisms and essential hypertension in Burkina Faso, West Africa. Int J Hypertens 2015: 979631. DOI: 10.1155/2015/979631

26. Imbalzano E, Vatrano M, Quartuccio S et al. Clinical impact of angiotensin I converting enzyme polymorphisms in subjects with resistant hypertension. Mol Cell Biochem 2017; 430 (1-2): 91-8. DOI: 10.1007/s11010-017-2957-5

27. Fung M.M, Rao F, Poddar S et al. Early inflammatory and metabolic changes in association with AGTR1 polymorphisms in prehypertensive subjects. Am J Hypertens 2011; 24 (2): 225-33. DOI: 10.1038/ajh.2010.210